GeneASIC is at the forefront of precision medicine, focusing on accelerating the analysis of sequencing data to harness the full potential of genomics. Their flagship product, the Next-Generation Sequencing Analysis Acceleration Platform (NGSAAP), offers ultra-fast analysis capabilities in a compact, on-premise solution. This platform is designed to deliver data center-grade performance, making it suitable for various applications in genomic research and healthcare. By streamlining the analysis process, GeneASIC aims to enhance the efficiency and accessibility of genomic data interpretation.

In addition to their NGSAAP, GeneASIC is developing Project XY, which provides comprehensive genome insights for lifespan healthcare planning. This innovative approach allows individuals to receive a customized genome-disease report based on a single whole genome sequencing (WGS) test, ensuring that the information remains relevant throughout their lifetime. The company's commitment to breaking down barriers in sequencing applications is evident in their user-friendly tools and solutions, which are backed by robust research and development efforts.

Taiwan

Based on the unique technology of simplifying, optimizing, and realizing the comprehensive genomics analysis algorithm, we deliver the hardware-accelerated genomic data analysis solution.

GeneASIC

Company Details